Literature DB >> 23685246

Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011.

William K Ampofo, Suleiman Al Busaidy, Nancy J Cox, Maria Giovanni, Alan Hay, Sue Huang, Stephen Inglis, Jackie Katz, Talat Mokhtari-Azad, Malik Peiris, Vilma Savy, Pathom Sawanpanyalert, Marietjie Venter, Anthony L Waddell, Geethani Wickramasinghe, Wenqing Zhang, Thedi Ziegler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23685246     DOI： 10.1016/j.vaccine.2013.05.049

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  14 in total

1.  Challenges in antigenic characterization of circulating influenza A(H3N2) viruses during the 2011-2012 influenza season: an ongoing problem?

Authors:  Athanasios Kossyvakis; Vasiliki Pogka; Aggeliki Melidou; Afroditi Moutousi; Georgia Gioula; Antonios Kalliaropoulos; Maria Exindari; Mary Emmanouil; Elina Horefti; Georgia Spala; Adam Meijer; Nikolaos Malisiovas; Andreas F Mentis
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

2.  Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas.

Authors:  K M Stucker; S A Schobel; R J Olsen; H L Hodges; X Lin; R A Halpin; N Fedorova; T B Stockwell; A Tovchigrechko; S R Das; D E Wentworth; J M Musser
Journal:  Euro Surveill       Date:  2015-05-07

3.  Data-driven interdisciplinary mathematical modelling quantitatively unveils competition dynamics of co-circulating influenza strains.

Authors:  Bin-Shenq Ho; Kun-Mao Chao
Journal:  J Transl Med       Date:  2017-07-28       Impact factor: 5.531

Review 4.  Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories.

Authors:  Scott E Hensley
Journal:  Curr Opin Virol       Date:  2014-08-11       Impact factor: 7.090

Review 5.  Challenges of Making Effective Influenza Vaccines.

Authors:  Sigrid Gouma; Elizabeth M Anderson; Scott E Hensley
Journal:  Annu Rev Virol       Date:  2020-05-11       Impact factor: 10.431

6.  Optimisation of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses.

Authors:  Yipu Lin; Yan Gu; Stephen A Wharton; Lynne Whittaker; Victoria Gregory; Xiaoyan Li; Simon Metin; Nicholas Cattle; Rodney S Daniels; Alan J Hay; John W McCauley
Journal:  Influenza Other Respir Viruses       Date:  2015-11       Impact factor: 4.380

Review 7.  Reverse Genetics Approaches for the Development of Influenza Vaccines.

Authors:  Aitor Nogales; Luis Martínez-Sobrido
Journal:  Int J Mol Sci       Date:  2016-12-22       Impact factor: 5.923

8.  Geographical heterogeneity and influenza infection within households.

Authors:  Day-Yu Chao; Kuang-Fu Cheng; Ying-Hen Hsieh; Tsai-Chung Li; Trong-Neng Wu; Chiu-Ying Chen
Journal:  BMC Infect Dis       Date:  2014-07-03       Impact factor: 3.090

9.  Improving the representativeness of influenza viruses shared within the WHO Global Influenza Surveillance and Response System.

Authors:  Dmitriy Pereyaslov; Galina Zemtsova; Christine Gruessner; Rodney S Daniels; John W McCauley; Caroline S Brown
Journal:  Influenza Other Respir Viruses       Date:  2016-03       Impact factor: 4.380

10.  An overview of the regulation of influenza vaccines in the United States.

Authors:  Jerry P Weir; Marion F Gruber
Journal:  Influenza Other Respir Viruses       Date:  2016-03-24       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.